Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy-Reference-Cited by-同舟云学术

Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy

Published:2022-12 Issue:12 Volume:175 Page:1707-1715
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

McCreary Erin K.¹^ORCID,Lemon Lara²^ORCID,Megli Christina²^ORCID,Oakes Amber³,Seymour Christopher W.⁴,Beigi Rich,McLaughlin Maribeth,Simhan Hyagriv,Wiesenfeld Harold,Lau Scarlet,Haley Michael,Trizzino Sandy,Steiner Ashley,Wiser Lauren,Adam Michelle,Borneman Tina,Huang David T.,Wadas Richard J.,Meyers Russell,Bariola J. Ryan,Schmidhofer Mark,Snyder Graham,Yealy Donald M.,Angus Derek C.,Minnier Tami,Shovel Judith A.,Albin Debbie,Marroquin Oscar C.,Collins Kevin,King Adam,Kip Kevin E.,Wisniewski Mary Kay,Sullivan Colleen,Axe Meredith,Garrard William,Montgomery Stephanie,Haidar Ghady,Kip Paula L.,Zapf Rachel L.,Ziska Sharen,Shirley Jessica,Medva Rebecca,

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (E.K.M.)

2. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, and Magee-Womens Research Institute, Pittsburgh, Pennsylvania (L.L., C.M.)

3. Department of Pharmacy, Magee-Womens Hospital, UPMC, Pittsburgh, Pennsylvania (A.O.)

4. Office of Healthcare Innovation, UPMC, Pittsburgh, Clinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, and Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (C.W.S.).

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Reference30 articles.

1. REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19

2. Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

3. Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

4. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection

5. A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention;Nature Immunology;2024-08-28

2. COVID-19 therapeutics for the pregnant patient;Seminars in Perinatology;2024-06

3. Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry;Drug Safety;2024-05-09

4. COVID-19 in pregnant women: a systematic review and meta-analysis on the risk and prevalence of pregnancy loss;Human Reproduction Update;2023-11-28

5. Efficacy and safety of therapies for COVID-19 in pregnancy: a systematic review and meta-analysis;BMC Infectious Diseases;2023-11-09